Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
20 auth.
S. Sharif,
G. Arreaza,
P. Zucker,
Q. Mi,
Jitin Sondhi,
O. Naidenko,
M. Kronenberg,
Y. Koezuka,
T. Delovitch,
J. Gombert,
...
M. Leite-de-Moraes,
C. Gouarin,
R. Zhu,
A. Hameg,
T. Nakayama,
M. Taniguchi,
F. Lepault,
A. Lehuen,
J. Bach,
A. Herbelin
|
|
9 |
2001 |
Social Media Posts